Aeterna Zentaris (AEZS) Short Interest Ratio & Short Volume $3.14 +0.14 (+4.50%) As of 08/27/2025 Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFDA EventsSEC FilingsTrendsBuy This Stock Aeterna Zentaris Short Interest DataAeterna Zentaris (AEZS) has a short interest of 5,300 shares, representing 0.18% of the float (the number of shares available for trading by the public). This marks a -7.02% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 7,305 shares to cover all short positions.Current Short Interest5,300 sharesPrevious Short Interest5,700 sharesChange Vs. Previous Month-7.02%Dollar Volume Sold Short$31.80 thousandShort Interest Ratio0.5 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares1,793,000 sharesFloat Size3,010,000 sharesShort Percent of Float0.18%Today's Trading Volume36,582 sharesAverage Trading Volume7,305 sharesToday's Volume Vs. Average501% Short Selling Aeterna Zentaris? Sign up to receive the latest short interest report for Aeterna Zentaris and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAEZS Short Interest Over TimeAEZS Days to Cover Over TimeAEZS Percentage of Float Shorted Over Time Aeterna Zentaris Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20245,300 shares $31.80 thousand -7.0%0.2%0.5 $6.00 6/30/20245,700 shares $25.19 thousand -38.7%0.2%0.5 $4.42 6/15/20249,300 shares $59.94 thousand -46.6%0.3%1 $6.45 5/31/202417,400 shares $168.61 thousand +171.9%0.6%1.9 $9.69 5/15/20246,400 shares $55.33 thousand +56.1%0.5%1 $8.65 4/30/20244,100 shares $35.10 thousand -75.7%0.3%0.9 $8.56 4/15/202416,900 shares $32.96 thousand -22.1%0.4%1.1 $1.95 3/31/202421,700 shares $47.52 thousand -25.7%0.5%1.3 $2.19 3/15/202429,200 shares $62.49 thousand +46.0%0.6%1.7 $2.14 2/29/202420,000 shares $38.20 thousand -13.8%0.4%1.4 $1.91 Get the Latest News and Ratings for AEZS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aeterna Zentaris and its competitors with MarketBeat's FREE daily newsletter. 2/15/202423,200 shares $43.15 thousand +10.0%0.5%1.6 $1.86 1/31/202421,100 shares $39.46 thousand -14.2%0.4%1.5 $1.87 1/15/202424,600 shares $51.17 thousand -17.7%0.5%1.7 $2.08 12/31/202329,900 shares $55.61 thousand -20.3%0.6%2.2 $1.86 12/15/202337,500 shares $80.06 thousand -11.6%0.8%3 $2.14 11/30/202342,400 shares $83.95 thousand -10.7%0.9%4 $1.98 11/15/202347,500 shares $70.30 thousand +1.5%1.0%5.4 $1.48 10/31/202346,800 shares $67.86 thousand -15.4%1.0%5.5 $1.45 10/15/202355,300 shares $97.88 thousand -10.8%1.1%5.9 $1.77 9/30/202362,000 shares $155 thousand +5.8%1.3%6.2 $2.50 9/15/202358,600 shares $155.29 thousand -7.1%1.2%6.2 $2.65 8/31/202363,100 shares $169.11 thousand -0.9%1.3%6.7 $2.68 8/15/202363,700 shares $181.55 thousand +1.9%1.3%6.1 $2.85 7/31/202362,500 shares $188.13 thousand -5.9%1.3%5.9 $3.01 7/15/202366,400 shares $190.57 thousand +6.9%1.4%6 $2.87 6/30/202362,100 shares $158.98 thousand -13.8%1.3%5.2 $2.56 6/15/202372,000 shares $203.76 thousand -12.0%1.5%5.5 $2.83 5/31/202381,800 shares $227.00 thousand +0.1%1.7%5.3 $2.78 5/15/202381,700 shares $242.65 thousand -14.4%1.7%5.2 $2.97 4/30/202395,400 shares $300.51 thousand +23.3%2.0%5.9 $3.15 4/15/202377,400 shares $202.79 thousand +3.8%1.6%5 $2.62 3/31/202374,600 shares $195.45 thousand +1.5%1.5%5 $2.62 3/15/202373,500 shares $196.25 thousand -15.5%1.5%4.9 $2.67 2/28/202387,000 shares $282.75 thousand +7.0%1.8%5.5 $3.25 2/15/202381,300 shares $284.55 thousand -5.8%1.7%5.3 $3.50 1/31/202386,300 shares $330.53 thousand -2.3%1.8%5.7 $3.83 1/15/202388,300 shares $330.68 thousand -9.1%1.8%5.8 $3.75 12/30/202297,100 shares $308.78 thousand +2.2%2.0%6.6 $3.18 12/15/202295,000 shares $316.73 thousand +0.7%2.0%6.6 $3.33 11/30/202294,300 shares $369.66 thousand -5.2%2.0%7 $3.92This is my Christian duty (Ad)“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.Watch Jim Rickards reveal the Old Testament Wealth Code 11/15/202299,500 shares $375.12 thousand -11.1%2.1%6.1 $3.77 10/31/2022111,900 shares $459.23 thousand +1.2%2.3%4.4 $4.10 10/15/2022110,600 shares $395.95 thousand -13.5%2.3%2.2 $3.58 9/30/2022127,800 shares $490.05 thousand -8.5%2.6%2.1 $3.83 9/15/2022139,600 shares $661.70 thousand -9.0%2.9%1.7 $4.74 8/31/2022153,400 shares $702.57 thousand -0.4%3.2%1.9 $4.58 8/15/2022154,000 shares $785.40 thousand +48.2%3.2%2 $5.10 7/31/2022103,900 shares $455.09 thousand +17.3%2.2%1.3 $4.38 7/15/202288,600 shares $526.95 thousand +13.2%1.8%1.7 $5.95 6/30/20221,960,000 shares $385.73 thousand -5.8%19.8%1.8 $0.20 6/15/20222,080,000 shares $357.76 thousand -0.5%21.1%3.5 $0.17 5/31/20222,090,000 shares $431.59 thousand -13.6%1.7%3.5 $0.21 5/15/20222,420,000 shares $592.90 thousand -6.9%2.0%4 $0.25 4/30/20222,600,000 shares $793 thousand -6.8%N/A5.2 $0.31 4/15/20222,790,000 shares $920.70 thousand -1.4%N/A4.8 $0.33 3/31/20222,830,000 shares $1.04 million -0.7%N/A4.4 $0.37 3/15/20222,850,000 shares $983.25 thousand +1.1%N/A3.3 $0.35 2/28/20222,820,000 shares $1.02 million -1.4%N/A3.1 $0.36 2/15/20222,860,000 shares $1.14 million -10.3%N/A2.9 $0.40 1/31/20223,190,000 shares $1.15 million -14.7%N/A2.8 $0.36 1/15/20223,740,000 shares $1.35 million No ChangeN/A2.9 $0.36 12/31/20213,740,000 shares $1.33 million +3.6%N/A2.9 $0.36 12/15/20213,610,000 shares $1.49 million +1.4%N/A1.7 $0.41 11/30/20213,560,000 shares $1.69 million -0.8%N/A1.6 $0.48 11/15/20213,590,000 shares $1.99 million -1.6%N/A1.7 $0.55 10/29/20213,650,000 shares $2.16 million -2.4%N/A1.7 $0.59 10/15/20213,740,000 shares $2.26 million +0.3%N/A1.8 $0.60 9/30/20213,730,000 shares $2.80 million -7.7%N/A1.9 $0.75 9/15/20214,040,000 shares $2.50 million -6.3%N/A3.6 $0.62 8/31/20214,310,000 shares $3.10 million -4.4%N/A3.3 $0.72 8/13/20214,510,000 shares $3.09 million -11.2%N/A2.7 $0.69 7/30/20215,080,000 shares $3.71 million +11.2%N/A2.9 $0.73 7/15/20214,570,000 shares $3.37 million +2.0%3.8%2 $0.74 6/30/20214,480,000 shares $3.93 million -15.8%3.7%1.8 $0.88 6/15/20215,320,000 shares $5.13 million +13.2%4.4%1.5 $0.96 5/28/20214,700,000 shares $4.16 million -2.9%3.9%0.7 $0.88 5/14/20214,840,000 shares $4.02 million -9.9%4.0%0.7 $0.83 4/30/20215,370,000 shares $5.91 million -12.4%4.4%0.4 $1.10 4/15/20216,130,000 shares $5.99 million -20.7%5.1%0.3 $0.98 3/31/20217,730,000 shares $8.73 million +89.5%6.4%0.4 $1.13 3/15/20214,080,000 shares $4.81 million +12.1%3.4%0.2 $1.18 2/26/20213,640,000 shares $4.08 million +4.6%3.1%0.2 $1.12 2/12/20213,480,000 shares $6.65 million -31.6%3.0%0.2 $1.91 1/29/20215,090,000 shares $3.71 million -2.9%8.7%0.4 $0.73 1/15/20215,240,000 shares $3.56 million +123.9%8.9%1 $0.68 12/31/20202,340,000 shares $1.00 million +23.8%4.0%0.7 $0.43 12/15/20201,890,000 shares $691.74 thousand +28.6%3.2%0.9 $0.37 11/30/20201,470,000 shares $602.70 thousand +90.2%2.5%0.7 $0.41 11/15/2020772,700 shares $269.90 thousand -19.8%1.3%0.3 $0.35 10/30/2020962,900 shares $318.72 thousand -24.2%1.6%0.4 $0.33He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.See his full breakdown of the seven stocks to own now 10/15/20201,270,000 shares $491.49 thousand -19.1%2.2%0.4 $0.39 9/30/20201,570,000 shares $551.07 thousand -13.7%2.7%0.4 $0.35 9/15/20201,820,000 shares $690.33 thousand -21.2%3.1%0.3 $0.38 8/31/20202,310,000 shares $1.08 million +35.9%3.9%0.5 $0.47 AEZS Short Interest - Frequently Asked Questions What is Aeterna Zentaris' current short interest? Short interest is the volume of Aeterna Zentaris shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 5,300 shares of AEZS short. 0.18% of Aeterna Zentaris' shares are currently sold short. Learn More on Aeterna Zentaris' current short interest. What is a good short interest percentage for Aeterna Zentaris? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.18% of Aeterna Zentaris' floating shares are currently sold short. Is Aeterna Zentaris' short interest increasing or decreasing? Aeterna Zentaris saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 5,300 shares, a drop of 7.0% from the previous total of 5,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aeterna Zentaris' float size? Aeterna Zentaris currently has issued a total of 1,793,000 shares. Some of Aeterna Zentaris' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aeterna Zentaris currently has a public float of 3,010,000 shares. How does Aeterna Zentaris' short interest compare to its competitors? 0.18% of Aeterna Zentaris' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aeterna Zentaris: Allarity Therapeutics, Inc. (4.92%), Incannex Healthcare Inc. (9.86%), Aytu BioPharma Inc. (10.84%), Finch Therapeutics Group, Inc. (0.01%), Ainos, Inc. (4.41%), 180 Life Sciences Corp. (30.55%), Lexaria Bioscience Corp. (1.74%), Edesa Biotech, Inc. (0.12%), Synlogic, Inc. (0.49%), LakeShore Biopharma Co., Ltd. (0.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply Company ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and lululemon athletica inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Aeterna Zentaris stock? Short selling AEZS is an investing strategy that aims to generate trading profit from Aeterna Zentaris as its price is falling. AEZS shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aeterna Zentaris? A short squeeze for Aeterna Zentaris occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AEZS, which in turn drives the price of the stock up even further. How often is Aeterna Zentaris' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AEZS, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies Allarity Therapeutics Short Interest Incannex Healthcare Short Interest Aytu BioPharma Short Interest Finch Therapeutics Group Short Interest Ainos Short Interest 180 Life Sciences Short Interest Lexaria Bioscience Short Interest Edesa Biotech Short Interest Synlogic Short Interest LakeShore Biopharma Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AEZS) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aeterna Zentaris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aeterna Zentaris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access